2019 Speakers

Jason found HCmed as a professional firm in the inhaled drug/device combination field. Since 2014, he leads HCmed team to design, develop, and manufacture highly effective mesh nebulizer and successfully invites Vivo capital to be a strategy investor in 2017. Based on the leading-edge mesh nebulizer expertise, combined with the strength of Taiwan’s world-class electrical…

Joe Condurso has more than 30 years of experience across the medical and information technology and services industry. Joe is an accomplished global executive with a successful track record for innovating and commercializing game changing medical devices, clinical information systems, mobile health solutions and telemedicine services within public, venture, and development stage organizations. He has…

Martijn Grinovero is the Chief Commercial Officer and Co-Founder of Amiko. He is responsible for leading Amiko’s commercial go-to-market teams, including sales, marketing, commercial relationships and business growth. Mr Grinovero has an MSc in Strategic Management from the Rotterdam School of Management (the Netherlands). Prior to joining Amiko, he worked at Alpha Founders Capital (Bangkok,…

Karl Kossen is an expert in the characterization of antifibrotic drugs and biomarkers of fibrotic disease, and he is currently Senior Vice President of Translational Science at Indalo. Dr. Kossen was previously Vice President of Disease Biology at InterMune, which successfully developed pirfenidone for the treatment of IPF. Following the acquisition of InterMune by Roche…

Mr. Tenenbaum serves as our Chief Executive Officer. Previously, Mr. Tenenbaum served as our Chief Financial Officer and Chief Business Officer. Prior to joining Bellerophon, Mr. Tenenbaum served as Chief Financial Officer and Chief Business Officer of Anterios, Inc., a clinical-stage biopharmaceutical company, from 2014 to 2016. Prior to that, Mr. Tenenbaum served as Chief…

Professor Andreas Fouras started his career in academic research, as a mechanical engineer with an interest in aerodynamics. His early research led to the development of new imaging algorithms to quantitatively measure airflow. Andreas was able to apply this novel wind tunnel quantification to clinical use through the development of XV Technology, which uniquely allows…

Jonathan Palley is the co-founder, co-inventor, and CEO of Spire Health. Having experienced the smog of Beijing for many years, Palley envisioned a device that would seamlessly be able to monitor and improve respiratory health conditions. Spire Health and its clinical-grade respiratory sensing remote patient monitoring device, Health Tags, represent the culmination of that effort.…

Maggie Galloway is CEO and co-founder of Inscope Medical Solutions, a medical device company that is developing and commercializing a novel laryngoscope system that combines several devices into one, improving patient safety and saving costs for hospitals. Before founding Inscope Medical, Maggie was an Innovation Consultant at Humana where she specialized in clinical product development…

Marko Topalović, PhD is a CEO of ArtiQ (Leuven, Belgium), an artificial intelligence (AI)-based software company that aims to become the trusted partner of medical practitioners for diagnosis, treatment, and follow-up of respiratory problems. Prior to co-founding the ArtiQ (University spin-off), as a postdoctoral researcher in the University Hospital in Leuven, Marko worked on improving…

Dr. Conoscenti received his M.D. from St George’s University School of Medicine. He completed his residency and chief residency at Hackensack University Medical Center. Following this he completed his pulmonary critical care fellowship at Norwalk Hospital/Yale University School of Medicine program. He practiced in a clinical academic program at Norwalk Hospital for 17 years serving…